Cargando…

Neuropharmacological evaluation of a novel 5-HT(3) receptor antagonist (6g) on chronic unpredictable mild stress-induced changes in behavioural and brain oxidative stress parameters in mice

AIM: The aim of the study was to evaluate a novel 5 HT(3) receptor antagonist (6g) on chronic stress induced changes in behavioural and brain oxidative stress parameter in mice. A complicated relationship exists among stressful stimuli, body's reaction to stress and the onset of clinical depres...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhatt, Shvetank, Radhakrishnan, Mahesh, Jindal, Ankur, Devadoss, Thangaraj, Dhar, Arghya Kusum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987189/
https://www.ncbi.nlm.nih.gov/pubmed/24741192
http://dx.doi.org/10.4103/0253-7613.129316
_version_ 1782479636647641088
author Bhatt, Shvetank
Radhakrishnan, Mahesh
Jindal, Ankur
Devadoss, Thangaraj
Dhar, Arghya Kusum
author_facet Bhatt, Shvetank
Radhakrishnan, Mahesh
Jindal, Ankur
Devadoss, Thangaraj
Dhar, Arghya Kusum
author_sort Bhatt, Shvetank
collection PubMed
description AIM: The aim of the study was to evaluate a novel 5 HT(3) receptor antagonist (6g) on chronic stress induced changes in behavioural and brain oxidative stress parameter in mice. A complicated relationship exists among stressful stimuli, body's reaction to stress and the onset of clinical depression. Chronic unpredictable stressors can produce a situation similar to human depression, and such animal models can be used for the preclinical evaluation of antidepressants. MATERIALS AND METHODS: In the present study, a novel and potential 5-HT(3) receptor antagonist (4-benzylpiperazin-1-yl)(3-methoxyquinoxalin-2-yl) methanone (6g) with good Log P (3.08) value and pA(2)(7.5) values, synthesized in our laboratory was investigated to study the effects on chronic unpredictable mild stress (CUMS)-induced behavioural and biochemical alterations in mice. Mice were subjected to different stress paradigms daily for a period of 28 days to induce depressive-like behaviour. RESULTS: The results showed that CUMS caused depression-like behaviour in mice, as indicated by the significant (P < 0.05) decrease in sucrose consumption and locomotor activity and increase in immobility the forced swim test. In addition, it was found that lipid peroxidation and nitrite levels were significantly (P < 0.05) increased, whereas glutathione levels, superoxide dismutase and catalase activities decreased in brain tissue of CUMS-treated mice. ‘6g’ (1 and 2 mg/kg, p.o., 21 days) and fluoxetine treatment (20 mg/kg, p.o., 21 days) significantly (P < 0.05) reversed the CUMS-induced behavioural (increased immobility period, reduced sucrose preference and decreased locomotor activity) and biochemical (increased lipid peroxidation; decreased glutathione levels, superoxide dismutase and catalase activities). However fluoxetine treatment (20 mg/kg, p.o., 21 days) significantly decreased the nitrite level in the brain while ‘6g’ (1 and 2 mg/kg, p.o., 21 days) did not show significant (P < 0.05) effect on the nitrite levels in brain. CONCLUSION: Compound ‘6g’ exerted antidepressant-like effects in behavioural despair paradigm in chronically stressed mice by restoring antioxidant mechanisms.
format Online
Article
Text
id pubmed-3987189
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-39871892014-04-16 Neuropharmacological evaluation of a novel 5-HT(3) receptor antagonist (6g) on chronic unpredictable mild stress-induced changes in behavioural and brain oxidative stress parameters in mice Bhatt, Shvetank Radhakrishnan, Mahesh Jindal, Ankur Devadoss, Thangaraj Dhar, Arghya Kusum Indian J Pharmacol Research Article AIM: The aim of the study was to evaluate a novel 5 HT(3) receptor antagonist (6g) on chronic stress induced changes in behavioural and brain oxidative stress parameter in mice. A complicated relationship exists among stressful stimuli, body's reaction to stress and the onset of clinical depression. Chronic unpredictable stressors can produce a situation similar to human depression, and such animal models can be used for the preclinical evaluation of antidepressants. MATERIALS AND METHODS: In the present study, a novel and potential 5-HT(3) receptor antagonist (4-benzylpiperazin-1-yl)(3-methoxyquinoxalin-2-yl) methanone (6g) with good Log P (3.08) value and pA(2)(7.5) values, synthesized in our laboratory was investigated to study the effects on chronic unpredictable mild stress (CUMS)-induced behavioural and biochemical alterations in mice. Mice were subjected to different stress paradigms daily for a period of 28 days to induce depressive-like behaviour. RESULTS: The results showed that CUMS caused depression-like behaviour in mice, as indicated by the significant (P < 0.05) decrease in sucrose consumption and locomotor activity and increase in immobility the forced swim test. In addition, it was found that lipid peroxidation and nitrite levels were significantly (P < 0.05) increased, whereas glutathione levels, superoxide dismutase and catalase activities decreased in brain tissue of CUMS-treated mice. ‘6g’ (1 and 2 mg/kg, p.o., 21 days) and fluoxetine treatment (20 mg/kg, p.o., 21 days) significantly (P < 0.05) reversed the CUMS-induced behavioural (increased immobility period, reduced sucrose preference and decreased locomotor activity) and biochemical (increased lipid peroxidation; decreased glutathione levels, superoxide dismutase and catalase activities). However fluoxetine treatment (20 mg/kg, p.o., 21 days) significantly decreased the nitrite level in the brain while ‘6g’ (1 and 2 mg/kg, p.o., 21 days) did not show significant (P < 0.05) effect on the nitrite levels in brain. CONCLUSION: Compound ‘6g’ exerted antidepressant-like effects in behavioural despair paradigm in chronically stressed mice by restoring antioxidant mechanisms. Medknow Publications & Media Pvt Ltd 2014 /pmc/articles/PMC3987189/ /pubmed/24741192 http://dx.doi.org/10.4103/0253-7613.129316 Text en Copyright: © Indian Journal of Pharmacology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Bhatt, Shvetank
Radhakrishnan, Mahesh
Jindal, Ankur
Devadoss, Thangaraj
Dhar, Arghya Kusum
Neuropharmacological evaluation of a novel 5-HT(3) receptor antagonist (6g) on chronic unpredictable mild stress-induced changes in behavioural and brain oxidative stress parameters in mice
title Neuropharmacological evaluation of a novel 5-HT(3) receptor antagonist (6g) on chronic unpredictable mild stress-induced changes in behavioural and brain oxidative stress parameters in mice
title_full Neuropharmacological evaluation of a novel 5-HT(3) receptor antagonist (6g) on chronic unpredictable mild stress-induced changes in behavioural and brain oxidative stress parameters in mice
title_fullStr Neuropharmacological evaluation of a novel 5-HT(3) receptor antagonist (6g) on chronic unpredictable mild stress-induced changes in behavioural and brain oxidative stress parameters in mice
title_full_unstemmed Neuropharmacological evaluation of a novel 5-HT(3) receptor antagonist (6g) on chronic unpredictable mild stress-induced changes in behavioural and brain oxidative stress parameters in mice
title_short Neuropharmacological evaluation of a novel 5-HT(3) receptor antagonist (6g) on chronic unpredictable mild stress-induced changes in behavioural and brain oxidative stress parameters in mice
title_sort neuropharmacological evaluation of a novel 5-ht(3) receptor antagonist (6g) on chronic unpredictable mild stress-induced changes in behavioural and brain oxidative stress parameters in mice
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987189/
https://www.ncbi.nlm.nih.gov/pubmed/24741192
http://dx.doi.org/10.4103/0253-7613.129316
work_keys_str_mv AT bhattshvetank neuropharmacologicalevaluationofanovel5ht3receptorantagonist6gonchronicunpredictablemildstressinducedchangesinbehaviouralandbrainoxidativestressparametersinmice
AT radhakrishnanmahesh neuropharmacologicalevaluationofanovel5ht3receptorantagonist6gonchronicunpredictablemildstressinducedchangesinbehaviouralandbrainoxidativestressparametersinmice
AT jindalankur neuropharmacologicalevaluationofanovel5ht3receptorantagonist6gonchronicunpredictablemildstressinducedchangesinbehaviouralandbrainoxidativestressparametersinmice
AT devadossthangaraj neuropharmacologicalevaluationofanovel5ht3receptorantagonist6gonchronicunpredictablemildstressinducedchangesinbehaviouralandbrainoxidativestressparametersinmice
AT dhararghyakusum neuropharmacologicalevaluationofanovel5ht3receptorantagonist6gonchronicunpredictablemildstressinducedchangesinbehaviouralandbrainoxidativestressparametersinmice